Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Activation Innate Immune System in Type 1 Diabetes
Conditions:   Diabetes Mellitus, Type 1;   Cardiovascular Diseases;   Innate Immune System;   Inflammation;   Metabolism Disorder, Glucose
Interventions:   Radiation: PET-CT (positron emission tomography - computer tomography);   Diagnostic Test: Blood drawn
Sponsors:   Radboud University;   European Foundation for the Study of Diabetes
Recruiting

Thu, 22 Feb 2018 12:00:00 EST


MedStar Diabetes Pathway Chart Reviews
Condition:   Type2 Diabetes Mellitus
Intervention:   Other: Intensive diabetes education and medication management
Sponsors:   Medstar Health Research Institute;   MedStar Health
Active, not recruiting

Thu, 22 Feb 2018 12:00:00 EST


Omega 3 and Fibre Intervention Study to Improve Metabolic Health
Conditions:   Metabolic Disease;   Immune Function;   Cardiovascular Diseases;   Systemic Inflammation
Interventions:   Dietary Supplement: Omega 3 fatty acid;   Dietary Supplement: Inulin fibre
Sponsor:   Guy's and St Thomas' NHS Foundation Trust
Not yet recruiting

Thu, 22 Feb 2018 12:00:00 EST


A Multicentre, Randomized, Controlled Study to Evaluate the Efficacy of Metformin in Preventing Diabetes in China
Condition:   PreDiabetes
Intervention:   Drug: metformin
Sponsor:   Chinese Association of Geriatric Research
Recruiting

Wed, 21 Feb 2018 12:00:00 EST


Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome
Conditions:   Psoriasis;   Metabolic Syndrome
Interventions:   Drug: Secukinumab;   Behavioral: Life-style intervention
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting

Wed, 21 Feb 2018 12:00:00 EST


Effect of Diabetes Mellitus on Spinal Block Criteria During Cesarean Section
Condition:   Spinal Anaesthesia
Intervention:   Procedure: spinal anaesthesia
Sponsor:   Assiut University
Not yet recruiting

Wed, 21 Feb 2018 12:00:00 EST


Functional Research of Emulsifiers in Humans
Condition:   Healthy
Intervention:   Other: Emulsifier-containing diet
Sponsors:   University of Pennsylvania;   Georgia State University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Wed, 21 Feb 2018 12:00:00 EST


Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes
Conditions:   Diabetic Neuropathy Peripheral;   Activities of Daily Living
Intervention:   Other: difficult activities of daily living in each group
Sponsor:   Okayama University
Completed

Wed, 21 Feb 2018 12:00:00 EST


Technology Assisted Stepped Collaborative Care Intervention
Conditions:   End-Stage Renal Disease;   Hemodialysis
Interventions:   Behavioral: TASCCI;   Other: Technology Delivered Health Education Intervention
Sponsors:   University of Pittsburgh;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of New Mexico
Not yet recruiting

Wed, 21 Feb 2018 12:00:00 EST


The Bariatric Surgery Registry
Condition:   Obesity
Intervention:  
Sponsors:   Monash University;   Australian Government Department of Health and Ageing;   University of Auckland, New Zealand
Recruiting

Wed, 21 Feb 2018 12:00:00 EST


A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition:   Duchenne Muscular Dystrophy
Interventions:   Drug: Vamorolone;   Drug: Prednisone;   Other: Placebo
Sponsors:   ReveraGen BioPharma, Inc.;   European Union;   Cooperative International Neuromuscular Research Group;   Newcastle University;   University of Pittsburgh
Not yet recruiting

Tue, 20 Feb 2018 12:00:00 EST


Analysis of the Microbiota and STEMI
Conditions:   STEMI;   Diabetes Mellitus;   Microbial Colonization
Intervention:   Diagnostic Test: collection of fecal material
Sponsor:   University of Campania "Luigi Vanvitelli"
Recruiting

Tue, 20 Feb 2018 12:00:00 EST


G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
Conditions:   Insulin Hypoglycemia;   Type 1 Diabetes Mellitus;   Severe Hypoglycemia
Interventions:   Drug: G-Pen;   Drug: Lilly Glucagon
Sponsors:   Xeris Pharmaceuticals;   SGS S.A.;   Integrated Medical Development
Recruiting

Tue, 20 Feb 2018 12:00:00 EST


Lowering Events in Non-proliferative Retinopathy in Scotland
Condition:   Diabetic Retinopathy
Interventions:   Drug: Fenofibrate 145 mg;   Drug: Placebo Oral Tablet
Sponsors:   University of Oxford;   National Institute for Health Research, United Kingdom;   University of Glasgow;   University of Aberdeen;   University of Dundee;   University of Edinburgh;   NHS Scotland Diabetic Retinopathy Screening Collaborative
Not yet recruiting

Tue, 20 Feb 2018 12:00:00 EST


Peer Support To Enhance The Shanghai Integration Model Of Diabetes Care: Extension & Dissemination
Condition:   Type 2 Diabetes Mellitus
Intervention:   Behavioral: Peer Support
Sponsors:   Shanghai 6th People's Hospital;   University of North Carolina, Chapel Hill;   Asian Center for Health Education;   Shanghai Municipal Commission of Health and Family Planning;   Merck Foundation
Active, not recruiting

Tue, 20 Feb 2018 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid

Wed, 21 Feb 2018 11:20:00 -0500


FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing

Fri, 16 Feb 2018 16:48:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine
FDA provides update on flu vaccines during this severe flu season

Thu, 15 Feb 2018 16:20:00 -0500


FDA expands treatment window for use of clot retrieval devices in certain stroke patients
FDA expands treatment window for use of clot retrieval devices in certain stroke patient

Thu, 15 Feb 2018 12:20:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs
FDA’s 5 guidance documents provide details for drug development for neurological conditions such as ALS and Alzheimer’s disease

Thu, 15 Feb 2018 09:31:00 -0500


FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint
FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer

Wed, 14 Feb 2018 13:46:00 -0500


FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults; new quick testing option to help reduce need for CT scans, radiation exposure for patients

Wed, 14 Feb 2018 13:21:00 -0500


FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients
FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

Tue, 13 Feb 2018 15:58:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition
Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition

Tue, 13 Feb 2018 15:33:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.
FDA announces on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.

Thu, 08 Feb 2018 11:43:00 -0500
Diabetes news from the American Diabetes Association

Latest Top (5) News